The effects of milk and a standard breakfast on the oral absorption of enoxacin were evaluated in eight healthy volunteers in a randomized, balanced, four-way crossover study. After an overnight fast, 400 mg enoxacin was given with water, milk, a breakfast or with a breakfast and milk. The extent of enoxacin absorption was not affected by any of the three treatments, and no statistically significant changes were found with respect to peak plasma enoxacin concentration or time to peak. We conclude that enoxacin can be taken together with food and dairy products.
Introduction Methods
Food can influence the rate and extent of drug absorption by a wide variety of mechanisms [1] . Studies with ciprofloxacin, enoxacin, lomefloxacin, ofloxacin, pefloxacin and temafloxacin have indicated that concomitant administration of food generally has no effect on the extent of absorption of these fluoroquinolones [2] [3] [4] [5] [6] [7] . However, we have recently demonstrated a decrease in the bioavailability of ciprofloxacin and norfloxacin when taken simultaneously with dairy products. Coadministration of milk lowered the extent of ciprofloxacin and norfloxacin absorption by 33% and 48%, respectively [8, 9] . The effect of yoghurt on the absorption of these fluoroquinolones was slightly greater. Furthermore, Bertino et al. [10] have recently reported an interaction between fleroxacin and a calcium-rich breakfast; the bioavailability and peak plasma concentration of fleroxacin were decreased by 10% and 27%, respectively [10] . Enoxacin is a broad-spectrum, synthetic fluoroquinolone antibacterial agent. Antacids and ranitidine decrease the absorption of enoxacin but it is not impaired by standard carbohydrate or high-fat meals [3, 12] . However, these meals did not contain any dairy products. The aim of this work was to study the effects of milk and a standard breakfast, eaten with or without milk, on the pharmacokinetics of enoxacin.
Protocol
A randomized, balanced, four-period crossover design was used. Each treatment was separated by a 7-day washout period. Eight volunteers (six males, two females) with a mean age of 22 years (range, 21 to 24 years) and a mean weight of 68 kg (range, 57 to 77 kg) participated in the study. The health of the subjects was assessed by medical history, physical examination and clinical laboratory tests. The volunteers were informed both verbally and in writing and written consent was obtained. The study protocol was approved by the Ethics Committee of the Turku University Medical School.
After an overnight fast, each subject took a single 400 mg dose of enoxacin (two 200 mg Gyramid tablets; Parke-Davis, Berlin, Germany) on four occasions: with 300 ml water, with 300 ml milk (Valio, Helsinki, Finland), with a standard breakfast or with a standard breakfast and milk (300 ml). The tablets were swallowed simultaneously with milk and within 5 min after completion of the meal. After drug intake, no food was allowed for 3 h. All volunteers were ambulant on all study days. The breakfast consisted of 60 g of brown bread, 25 g of cheese, 10 g of butter, 1 egg, 200 ml of orange juice and 150 ml of non-sweetened black coffee. This meal Venous blood samples were collected by separate venepuncture in heparinized tubes just prior to the enoxacin dose and at 0.5, 1, 1.5, 2, 3, 5, 7, 9 and 24 h thereafter. Plasma was separated within 30 min. Urine was collected from 0 to 9 and 9 to 24 h. The plasma and urine samples were stored at -20°C until analyzed. Appropriate precautions were taken to protect samples from exposure to light during collection, storage and analysis.
Analytical methods
Enoxacin concentrations in plasma and urine were assayed by high-performance liquid chromatography with u.v.-detection, as described by Griggs & Wise [13] . The intra-day coefficients of variation for the low and high control plasma samples were 2.7% (mean, 0.30 gg ml-'; n = 6) and 2.0% (mean, 1.5 jg mr,; n = 6). The inter-day coefficients of variation for the control samples were 3.6% (mean, 0.29 jg ml-; n = 9) and 2.9% (mean, 1.7 jig ml-; n = 9). [10] found that the absorption of fleroxacin was decreased 10% (P < 0.05) by concomitant ingestion of a breakfast containing 393 mg of calcium [10] .
Enoxacin absorption was not influenced by milk. In previous studies, milk was found to lower the absorption of ciprofloxacin and norfloxacin by 33% and 48%, respectively [8, 9] , while the absorption of ofloxacin was not impaired by concomitant ingestion of the same volume of milk [6, 11] . Similar results were obtained with yoghurt [8, 9, 11] .
Metal cations inhibit the absorption of fluoroquinolones by forming poorly absorbable chelate complexes [15] . Accordingly, the decreased absorption of some fluoroquinolones by dairy products is probably related to calcium ions. Three hundred millilitres of milk contains 360 mg of calcium, whereas the amount of other metal ions in dairy products is negligible. Calcium-containing antacids are known to impair the absorption of fluoroquinolones. Coadministration of 3.4 g of calcium carbonate (corresponding to 1.4 g of calcium) with ciprofloxacin (750 mg) decreased the bioavailability of the latter by 40% [16] . Similarly, the bioavailability of norfloxacin was decreased by 60% when given 5 min after calcium carbonate [17] . To our knowledge, the effect of calcium containing antacids on the absorption of enoxacin has not been studied.
The concurrent presence of calcium and fluoroquinolones in the gastrointestinal tract is not the sole prerequisite for an interaction to occur. Before chelation is possible, calcium and fluoroquinolone must be dissolved in the gastric contents. Moreover, solid components of meals may absorb liquid dairy products. The design of this study included a liquid dairy product (milk) and a breakfast, containing 360 mg and 332 mg of calcium, respectively, administered separately and in combination. None of these calcium-containing treatments affected the absorption of enoxacin. Thus, it appears that the affinity of enoxacin for calcium ions is less than that of ciprofloxacin, norfloxacin and fleroxacin. The dissolution of enoxacin may also differ from that of other fluoroquinolones. Mechanisms other than chelation may also account for interactions involving enoxacin since intravenous ranitidine lowered its bioavailability by 40% [12] .
In conclusion, our findings suggest that enoxacin can be taken concomitantly with food and dairy products without compromising its oral absorption.
